These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24476441)

  • 21. Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms.
    van Noord JA; Aumann JL; Janssens E; Smeets JJ; Zaagsma J; Mueller A; Cornelissen PJ
    Respir Med; 2010 Jul; 104(7):995-1004. PubMed ID: 20303247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled glucocorticoids and COPD exacerbations.
    Cosio M; Baraldo S; Saetta M
    N Engl J Med; 2015 Jan; 372(1):92. PubMed ID: 25551536
    [No Abstract]   [Full Text] [Related]  

  • 24. Bronchodilator safety in chronic obstructive pulmonary disease-reply.
    Stanbrook MB; Campitelli M; Gershon A
    JAMA Intern Med; 2014 Apr; 174(4):648. PubMed ID: 24711200
    [No Abstract]   [Full Text] [Related]  

  • 25. Tiotropium Respimat inhaler and the risk of death in COPD.
    Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
    N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchodilator safety in chronic obstructive pulmonary disease: time to focus?
    van Dijk WD; Käyser SC
    JAMA Intern Med; 2014 Apr; 174(4):647. PubMed ID: 24711198
    [No Abstract]   [Full Text] [Related]  

  • 27. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS; Carnathan BJ; Imus S; Colice GL
    Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
    Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect].
    MMW Fortschr Med; 2002 Jun; 144(26):52. PubMed ID: 12154479
    [No Abstract]   [Full Text] [Related]  

  • 30. ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD.
    Shafazand S
    Ann Intern Med; 2013 Jun; 158(12):JC2. PubMed ID: 23778926
    [No Abstract]   [Full Text] [Related]  

  • 31. Discontinuing inhaled steroids might not be safe in severe COPD cases.
    Laniado-Laborín R
    Evid Based Med; 2015 Apr; 20(2):57. PubMed ID: 25595701
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.
    Dong YH; Lin HH; Shau WY; Wu YC; Chang CH; Lai MS
    Thorax; 2013 Jan; 68(1):48-56. PubMed ID: 23042705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE; Khmel'kova NG; Belin-Atarac B
    Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Not Available].
    Fischer S
    Med Monatsschr Pharm; 2014 Feb; 37(2):79-80. PubMed ID: 24624613
    [No Abstract]   [Full Text] [Related]  

  • 35. ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation.
    Stanbrook MB
    Ann Intern Med; 2015 Mar; 162(6):JC5. PubMed ID: 25775348
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm?
    Barnes NC; Jones PW; Davis KJ
    Thorax; 2014 Jun; 69(6):598-9. PubMed ID: 24550061
    [No Abstract]   [Full Text] [Related]  

  • 37. Response.
    Nishimura N
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):121. PubMed ID: 23550603
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhaled glucocorticoids and COPD exacerbations.
    Magnussen H; Tetzlaff K; Calverley PM
    N Engl J Med; 2015 Jan; 372(1):93-4. PubMed ID: 25551535
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhaled glucocorticoids and COPD exacerbations.
    Singanayagam A; Johnston SL; Mallia P
    N Engl J Med; 2015 Jan; 372(1):92-3. PubMed ID: 25551537
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhaled glucocorticoids and COPD exacerbations.
    Brightling CE; Pavord ID; Bafadhel M
    N Engl J Med; 2015 Jan; 372(1):93. PubMed ID: 25551538
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.